cryptococcus gattii - dofaq.co
Disseminated Cryptococcal Gattii infection in a patient with anti-granulocyte-macrophage colony-stimulating-factor autoantibody: a case report
Single nucleotide polymorphisms are associated with strain-specific virulence differences among clinical isolates of Cryptococcus neoformans
Systematic Review of Cryptococcus neoformans Seroprevalence, Antifungal Susceptibility, and Pathogenesis in Patients With HIV/AIDS on Combination Antiretroviral Therapy in Abuja, Nigeria
Virulence factors released by extracellular vesicles from Cryptococcus neoformans
Cryptococcal nutrient acquisition and pathogenesis: dining on the host
Cryptococcus neoformans osteomyelitis of the right ankle Diagnosed by | IDR
Genetic mutations in Cryptococcus neoformans pyrimidine salvage pathway enzymes contribute to reduced susceptibility against 5-fluorocytosine
Cryptococcus gattii : a resurgent fungal pathogen
Editorial: Global excellence in fungal pathogenesis: Central and South America
A case of primary cutaneous Cryptococcus neoformans infection
Characterization of Environmental Sources of the Human and Animal Pathogen Cryptococcus gattii in British Columbia, Canada, and the Pacific Northwest of the United States
Screening for cryptococcal antigenemia and meningeal cryptococcosis, genetic characterization of Cryptococcus neoformans in asymptomatic patients with advanced HIV disease in Kinshasa, Democratic Republic of Congo | Scientific Reports
Novel mitochondrial-targeted alkyl chains act as fungal specific inhibitors of C. neoformans
Disseminated Cryptococcus over pancreas, lung, and brain: a case report
Comparison of mNGS with conventional methods for diagnosis of cryptococcal meningitis: a retrospective study
Loss of the putative Rab GTPase, Ypt7, impairs the virulence of Cryptococcus neoformans
Pathogen-derived extracellular vesicles mediate virulence in the fatal human pathogen Cryptococcus gattii
Immune evasion by Cryptococcus gattii in vaccinated mice coinfected with C. neoformans
Standardisation of high throughput microdilution antifungal susceptibility testing for Candida albicans and Cryptococcus neoformans
